INM-176

· Whanin Pharmaceutical Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for INM-176, covering 2011-06-13 to 2011-06-13. Get the full timeline:

Most recent: Clinical Trial Update: An Efficacy and Safety Study of INM-176 for the Treatment of Patients With Alzheimer Type Dementia [Phase 3]